Clinical Trials for Refractory Grade 3a Follicular Lymphoma

Find clinical trials for refractory grade 3a follicular lymphoma. Discover research opportunities and treatment options in your area.

3 Active Trials Found

Showing 3 trials on this page

Page 1 of 1

Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

NCT ID: NCT06859008

This clinical trial is studying the combination of two medications, zanubrutinib and sonrotoclax, to treat patients from underrepresented racial and ethnic backgrounds who have a type of blood canc...

Recruiting

Phase: PHASE1 Type: interventional Locations: Duarte, California, United States

Epcoritamab and Tazemetostat for the Treatment of Relapsed or Refractory Grade I-IIIa Follicular Lymphoma

NCT ID: NCT06575686

This clinical trial is investigating the combination of two medications, epcoritamab and tazemetostat, to see if they can effectively treat patients with follicular lymphoma that has come back afte...

Recruiting

Phase: PHASE2 Type: interventional Locations: Duarte, California, United States, Irvine, California, United States

Mosunetuzumab and Polatuzumab Vedotin for the Treatment of Patients with Relapsed or Refractory Grade 1-3a Follicular Lymphoma

NCT ID: NCT06453044

This clinical trial is exploring the effectiveness of two medicines, mosunetuzumab and polatuzumab vedotin, for treating patients with a type of cancer called follicular lymphoma that has either co...

Recruiting

Phase: PHASE2 Type: interventional Locations: Duarte, California, United States, Irvine, California, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions